
Novartis puts $12B on the table
Wall Street Breakfast
00:00
Novartis Agrees to Buy Avidity for $12B
Julie Morgan reports Novartis' $72-per-share offer for Avidity Biosciences and market reactions, including analyst commentary and related RNA winners.
Play episode from 00:37
Transcript


